| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Whitehawk Therapeutics, Inc.
13G
WHWK · 00032Q104
|
5.6% |
11/16/2026
Event 9/30/2026
|
|||
| Dellora Investments LP | 5.6% | ||||
| Kevin Pyun | 5.6% | ||||
|
Verrica Pharmaceuticals Inc.
13G
VRCA · 92511W207
|
5.2% |
11/16/2026
Event 9/30/2026
|
|||
| Dellora Investments LP | 5.2% | ||||
| Kevin Pyun | 5.2% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 5
TENX · 88032L605
|
6.4% |
10/9/2026
Event 10/2/2026
|
|||
| Dellora Investments Master Fund LP | 5.5% | ||||
| Dellora Investments LP | 6.4% | ||||
| Kevin Pyun | 6.4% | ||||
|
Rezolute, Inc.
13G
RZLT · 76200L309
|
5.9% |
8/12/2026
Event 8/5/2026
|
|||
| Dellora Investments Master Fund LP | 5.1% | ||||
| Dellora Investments LP | 5.9% | ||||
| Kevin Pyun | 5.9% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 4
TENX · 88032L605
|
2.3% |
5/15/2026
Event 3/31/2026
|
|||
| Dellora Investments Master Fund LP | 2.0% | ||||
| Dellora Investments LP | 2.3% | ||||
| Kevin Pyun | 2.3% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 3
TENX · 88032L605
|
6.4% |
2/17/2026
Event 12/31/2025
|
|||
| Dellora Investments Master Fund LP | 5.7% | ||||
| Dellora Investments LP | 6.4% | ||||
| Kevin Pyun | 6.4% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 2
TENX · 88032L605
|
8.8% |
4/4/2025
Event 3/5/2025
|
|||
| Dellora Investments Master Fund LP | 7.7% | ||||
| Dellora Investments LP | 8.8% | ||||
| Kevin Pyun | 8.8% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 1
TENX · 88032L605
|
10.3% |
1/15/2025
Event 1/8/2025
|
|||
| Dellora Investments Master Fund LP | 9.0% | ||||
| Dellora Investments LP | 10.3% | ||||
| Kevin Pyun | 10.3% | ||||
|
Palvella Therapeutics, Inc.
13G/A
Amendment 2
PVLA · 697947109
|
1.3% |
12/17/2024
Event 12/13/2024
|
|||
| Dellora Investments Master Fund LP | 1.1% | ||||
| Dellora Investments LP | 1.3% | ||||
| Kevin Pyun | 1.3% | ||||
|
Pieris Pharmaceuticals, Inc.
13G/A
Amendment 1
PIRS · 720795202
|
10.7% |
12/6/2024
Event 11/6/2024
|
|||
| Dellora Investments Master Fund LP | 9.3% | ||||
| Dellora Investments LP | 10.7% | ||||
| Kevin Pyun | 10.7% | ||||
|
Tenax Therapeutics, Inc.
13G
TENX · 88032L605
|
6.9% |
12/5/2024
Event 11/27/2024
|
|||
| Dellora Investments Master Fund LP | 5.9% | ||||
| Dellora Investments LP | 6.9% | ||||
| Kevin Pyun | 6.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.